Nikang Therapeutics

Venture investors still love drug developers
EP Vantage
Tue, 07/6/21 - 10:32 am
funding
venture capital
Adagio Therapeutics
Insilico
Umoja Biopharma
Nikang Therapeutics
Apollo Therapeutics